Life sciences & healthcare
Click here to find out more
Biologics and biosimilars litigation update
7 August 2020
QUICK READ
Brexit
Click here to find out more
Brexit readiness for overseas medical devices manufacturers: trade marks
6 August 2020
QUICK READ
by multiple authors
Life sciences & healthcare
Click here to find out more
Return to work: key issues for life sciences
4 August 2020
QUICK READ
by Helen Farr and Adrian Toutoungi
Synapse
Click here to find out more
Private equity investment in life sciences sector
30 July 2020
IN-DEPTH ANALYSIS
by multiple authors
Life sciences & healthcare
Click here to find out more
Licensing out: Try not to get benched
27 July 2020
IN-DEPTH ANALYSIS
by Colin McCall and Justyna Ostrowska
Life sciences & healthcare
Click here to find out more
Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents
27 July 2020
QUICK READ
by multiple authors
Patents & innovation
Click here to find out more
IP: Licensing and insolvency
23 July 2020
QUICK READ
by multiple authors
Synapse
Click here to find out more
UK increases scrutiny of tech and life sciences deals
13 July 2020
IN-DEPTH ANALYSIS
Technology, media & communications
Click here to find out more
Future Fund: update to connected person test following Taylor Wessing (and others) request for changes
9 July 2020
QUICK READ
by multiple authors
Life sciences & healthcare
Click here to find out more
US buys up entire stock of remdesivir
Time to intervene?
3 July 2020
QUICK READ
by Judith Krens
Technology, media & communications
Click here to find out more
Future Fund extended to companies who participated in overseas accelerator programmes
1 July 2020
QUICK READ
by Angus Miln and Howard Palmer